
Upstream Bio's CEO Rand Sutherland discusses today's severe asthma data for verekitug, a TSLP receptor antagonist
BiotechTV - News
00:00
Intro
Ellucent branding and episode opening in Boston, host Brad introduces the interview context and guest.
Play episode from 00:00
Transcript


